Skip to main content

Advertisement

Log in

Prognostic features at diagnosis of chronic myeloid leukaemia with special emphasis on histological parameters

  • Original Articles
  • Published:
Medical Oncology and Tumor Pharmacotherapy Aims and scope Submit manuscript

Abstract

A clinicopathological study was performed on 115 patients (56 males, 59 females; median age 48 yr) with chronic myeloid leukaemia (CML) to reveal initial clinical, but particularly histomorphological features of predictive value for survival. All patients had a trephine biopsy of the bone marrow and entered this study without prior selection. Overall survival was 36 ± 27 months. In addition to multiple interactions between various disease features, multivariate regression analysis showed that of the clinical parameters age, liver size and level of LDH were primarily and most closely associated with prognosis. Of the histomorphological variables, megakaryocytes > 60 mm−2 bone marrow area and fibrosis displayed an unfavourable impact on survival on univariate calculation. On multivariate analysis, however, only pseudo-Gaucher cells remained significant, i.e. exerted an independent and favourable influence on prognosis. Histological features of predictive value were reviewed together with the different categories of a histopathological classification proposed for chronic myeloproliferative diseases by Georgii and co-workers.13

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Jacquillat C, Chastang C, Tanzeret al.: Facteurs de prognostic de la leucemie myeloide chronique. A propos de 798 observations.Nouv Revue fr Hémat 15, 229 (1975).

    CAS  Google Scholar 

  2. Hossfeld D K: Chronic myelocytic leukemia: cytogenetic finclings and their relations to pathogenesis and clinic.Semin Hemat 8, 53 (1975).

    CAS  Google Scholar 

  3. Schilling R F, Crowley J J: Prognostic signs in chronic myelocytic leukemia.Am J Hemat 7, 1 (1979).

    Article  PubMed  CAS  Google Scholar 

  4. Tura S, Baccarani M, Corbelli G: Staging of chronic myeloid leukaemia.Br J Haemal 47, 105 (1981).

    Article  CAS  Google Scholar 

  5. Gomez G A, Sokal J E, Walsh D: Prognostic features at diagnosis of chronic myclocytic leukemia.Cancer 47, 470 (1981).

    Article  Google Scholar 

  6. Cervantes F, Rozman C: A multivariate analysis of prognostic factors in chronic myeloid leukemia.Blood 60, 1298 (1982).

    PubMed  CAS  Google Scholar 

  7. Dacie J, Galton DAG, Bagshaw K Det al: Randomized trial of splenectomy in Ph-1-positive chronic granulocytic leukaemia, inclucling an analysis of prognostic features.Br J Haemal 54, 415 (1983).

    Article  Google Scholar 

  8. Sokal J E, Cox E B, Baccarani, Met al.: Prognostic discrimination in “good-risk” chronic granulocytic leukemia.Blood 63, 789 (1984).

    PubMed  CAS  Google Scholar 

  9. Gralnick H R, Harbor J, Vogel C: Myelofibrosis in chronic granulocytic leukemia.Blood 37, 152 (1971).

    PubMed  CAS  Google Scholar 

  10. Devred C, Diebold J: La myelofibrose au cours des hemopathies. Valeur diagnostique et prognostique. A propos de 402 observations.Sem Hôp Paris 50, 1625 (1974).

    PubMed  CAS  Google Scholar 

  11. Clough V, Geary C G, Hashmi K, Davson J, Knowlson T: Myelofibrosis in chronic granulocytic leukaemia.Br J Haemat 42, 515 (1979).

    Article  CAS  Google Scholar 

  12. Lazzarino M, Morra E, Castello A, Inverardi D, Coci A, Pagnucco G, Magrini U, Zei G, Bernasconi C: Myelofibrosis in chronic granulocytic leukaemia: clinicopathologic correlations and prognostic significance.Br J Haemat 64, 227 (1986).

    Article  CAS  Google Scholar 

  13. Georgii A, Vykoupil K F, Thiele J: Classification of chronic myeloproliferative diseases by bone marrow biopsies. Hematological and cytogenetic finclings and clinical course.Biblthca haemat 50, 41 (1984).

    Google Scholar 

  14. Frisch B, Bartl R, Burkhardt R, Jäger K, Mahl G, Kettner G: Classification of myeloproliferative disorders by bone marrow histology.Biblthca haemat 50, 57 (1984).

    Google Scholar 

  15. Burkhardt R, Bartl R, Jäger K, Frisch B, Kettner G, Mahl G, Sund M: Working classification of chronic myeloproliferative disorders based on histological, haematological and clinical finclings.J clin Path 39, 237 (1986).

    Article  PubMed  CAS  Google Scholar 

  16. Georgii A: Histopathology of the bone marrow in human chronic leukaemias, in Neth R, Gallo R C, Hofshneider P H, Mannweiler K (eds):Modern Trends in Human Leukemia III, pp. 59–70. Berlin, Springer (1979).

    Google Scholar 

  17. Georgii A, Vykoupil K F, Thiele J: Chronic megakaryocytic granulocytic myelosis — CMGM. A subtype of chronic myeloid leukemia.Virchows Arch path Anat Hist 389, 253 (1980).

    Article  CAS  Google Scholar 

  18. Jamshidi K, Swaim W R: Bone marrow biopsy with unaltered architecture: a new biopsy device.J Lab clin Med 77, 335 (1971).

    PubMed  CAS  Google Scholar 

  19. Schaefer H E: Leukopoese und myeloproliferative Erkrankungen, in Remmele W (ed):Pathologie, Vol.I, pp. 356–452. Berlin, Springer (1984).

    Google Scholar 

  20. Pearson E S, Hartley H O:Biometrika Tables for Statisticians I and II. London, Cambridge University Press (1970, 1972).

    Google Scholar 

  21. Spearman C: The proof and measurement of association between two things.Am J Psych 15, 72 (1904a).

    Article  Google Scholar 

  22. Spearman C: General intelligence objectively determined and measured.Am J Psych 15, 201 (1904b).

    Article  Google Scholar 

  23. Morrison D F:Multivariate Statistical Methods. New York, McGraw-Hill (1967).

    Google Scholar 

  24. Fisher R A:Statistical Methods for Research Workers. Eclinburgh, Oliver and Boyd (1972).

    Google Scholar 

  25. Sokal J E: Evaluation of survival data for chronic myelocytic leukemia.Am J Hemat 1, 493 (1976).

    Article  PubMed  CAS  Google Scholar 

  26. Mason J E, Devita V T, Canellos G P: Thrombocytosis in chronic granulocytic leukemia: incidence and clinical significance.Blood 44, 483 (1974).

    PubMed  Google Scholar 

  27. Wolf D J, Silver R T, Coleman M: Factors associated with prolonged survival in chronic myeloid leukemia.Cancer 42, 1957 (1978).

    Article  PubMed  CAS  Google Scholar 

  28. Albrecht M: “Gaucher-Zellen” bei chronisch myeloischer Leukämie.Blut 13, 169 (1966).

    Article  PubMed  CAS  Google Scholar 

  29. Smith W C, Kaneshiro M M, Goldstein B D, Parker J W, Lukes R J: Gaucher cells in chronic granulocytic leukemia.Lancet 2, 780 (1968).

    Article  PubMed  CAS  Google Scholar 

  30. Gerdes J, Marathe R L, Bloodworth J M B, Mackinney A A: Gaucher cells in chronic granulocytic leukemia.Archs Path 88, 194 (1969).

    CAS  Google Scholar 

  31. Rosner F, Dosik H, Kaiser S S, Lee S L, Morrison A N: Gaucher cells in leukemia.J Am Med Ass 209, 935 (1969).

    Article  CAS  Google Scholar 

  32. Kattlove H E, Williams J C, Gaynor E, Spivack M, Bradley R M, Brady R O: Gaucher cells in chronic myelocytic leukemia: an acquired abnormality.Blood 33, 279 (1969).

    Google Scholar 

  33. Lee R E, Ellis L D: The storage cells of chronic myelogenous leukemia.Lab Invest 24, 261 (1971).

    PubMed  CAS  Google Scholar 

  34. Dosik H, Rosner F, Sawitsky A: Acquired lipoidosis: Gaucher-like cells and “blue cells” in chronic granulocytic leukemia.Semin Hemat 9, 309 (1972).

    PubMed  CAS  Google Scholar 

  35. Albrecht M: Zur Problematik der “Gaucher-Zellen” bei chronisch-myeloischer Leukämie.Klin Wschr 47, 778 (1969).

    Article  PubMed  CAS  Google Scholar 

  36. Keyserlingk D, Boll I, Albrecht M: Elektronenmikroskopie und Cytochemie der “Gaucher-Zellen” bei chronischer Myelose.Klin Wschr 50, 510 (1972).

    Article  PubMed  CAS  Google Scholar 

  37. Albrecht M: Ergebnisse von Langzeitbeobachtungen bei Patienten mit chronisch myeloischer Leukämie, in Gross R, Van de Loo (eds):Leukämie, pp. 399–404. Heidelberg, Springer (1972).

    Google Scholar 

  38. Thiele J, Fohlmeister I, Vonneguth B, Zankovich R, Fischer R: The prognostic implication of clinical and histological features in Ph 1 + s-chronic myelocytic leukaemia (CML).Anticancer Res 6, 1401 (1986).

    PubMed  CAS  Google Scholar 

  39. Schmahl M: Pseudogaucherzellen und Megakaryozyten bei der chronischen myeloischen Leukämie. Inauguraldissertation. Köln (1983).

    Google Scholar 

  40. Castro-Malaspina H: Pathogenesis of myelofibrosis: role of ineffective megakaryopoiesis and megakaryocyte components, in Berk P, Castro-Malaspina H, Wasserman L (eds):Myelofibrosis and the Biology of Connective Tissue, pp. 427–454. New York, Alan R. Liss (1984).

    Google Scholar 

  41. Burstein S A, Malpass T W, Yee E, Kaclin M, Brigden M, Adamson J W, Harker L A: Platelet factor-4 excretion in myeloproliferative disease: implications for the aetiology of myelofibrosis.Br J Haemal 57, 383 (1984).

    Article  CAS  Google Scholar 

  42. Frisch B, Bartl R: Histology of myelofibrosis and osteomyelosclerosis, in Lewis S M (ed):Myelo-fibrosis. Pathophysiology and Clinical Management, pp. 51–86. New York, Marcel Dekker (1985).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Supported in part by a grant from the Moritz Foundation, Cologne, West Germany.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thiele, J., Thienel, C., Zankovich, R. et al. Prognostic features at diagnosis of chronic myeloid leukaemia with special emphasis on histological parameters. Med. Oncol. & Tumor Pharmacother. 5, 49–60 (1988). https://doi.org/10.1007/BF03003181

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03003181

Key words

Navigation